These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 6327517)
1. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system. Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517 [TBL] [Abstract][Full Text] [Related]
2. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat. Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815 [TBL] [Abstract][Full Text] [Related]
3. No evidence on significant roles of the prostaglandin-thromboxane and kallikrein-kinin system in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin. Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K Clin Exp Hypertens A; 1987; 9(2-3):323-8. PubMed ID: 2440625 [TBL] [Abstract][Full Text] [Related]
4. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats. Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184 [TBL] [Abstract][Full Text] [Related]
5. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats. Yasujima M; Abe K; Tanno M; Sato K; Kasai Y; Seino M; Chiba S; Goto T; Omata K; Tajima J Clin Exp Hypertens A; 1984; 6(7):1297-310. PubMed ID: 6565534 [TBL] [Abstract][Full Text] [Related]
6. Renal prostaglandin E in the hypotensive mechanism of MK-421 in conscious rats. Yasujima M; Abe K; Tanno M; Kasai Y; Sato K; Tajima J; Kudo K; Tsunoda K; Yoshinaga K J Hypertens; 1984 Dec; 2(6):623-9. PubMed ID: 6098610 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system. Filep J; Rigter B; Földes-Filep E J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174 [TBL] [Abstract][Full Text] [Related]
8. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O; Shimamoto K Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450 [TBL] [Abstract][Full Text] [Related]
9. Role of the endogenous angiotensin II in the antihypertensive effect of MK 421 in rats made hypertensive by norepinephrine or vasopressin. Yasujima M; Abe K; Tanno M; Yoshinaga K Adv Exp Med Biol; 1989; 247A():35-8. PubMed ID: 2557748 [TBL] [Abstract][Full Text] [Related]
10. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats. Schiffrin EL; Gutkowska J; Thibault G; Genest J Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602 [TBL] [Abstract][Full Text] [Related]
11. Role of vasopressin in regulation of renal kinin excretion in Long-Evans and diabetes insipidus rats. Kauker ML; Crofton JT; Share L; Nasjletti A J Clin Invest; 1984 Mar; 73(3):824-31. PubMed ID: 6561201 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats. Emond C; Bompart G; Rakotoarivony J; Bascands JL; Pecher C; Adam A; Tarrade T; Berthet P; Girolami JP J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717 [TBL] [Abstract][Full Text] [Related]
13. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
14. [Effect of enalapril maleate (MK-421) on blood pressure, renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension]. Shionoiri H; Akema N; Tanaka K; Miyazaki N; Gotoh E; Kaneko Y Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):759-65. PubMed ID: 6096606 [No Abstract] [Full Text] [Related]
15. Decreased urinary active and inactive kallikrein by chronic infusion of vasopressin in conscious rats. Yasujima M; Abe K; Tanno M; Omata K; Kasai Y; Sato M; Kimura T; Yoshinaga K Tohoku J Exp Med; 1985 Feb; 145(2):215-22. PubMed ID: 3846407 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor inhibits the hypertension induced by chronic infusion of norepinephrine in conscious rats. Yasujima M; Abe K; Kohzuki M; Tanno M; Kasai Y; Sato M; Omata K; Kudo K; Tsunoda K; Takeuchi K Circ Res; 1985 Sep; 57(3):470-4. PubMed ID: 3161659 [TBL] [Abstract][Full Text] [Related]
17. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats]. Bönner G; Hirzel B; Ganten D; Kaufmann W Z Kardiol; 1988; 77 Suppl 2():85-91. PubMed ID: 2841816 [TBL] [Abstract][Full Text] [Related]
19. Effect of norepinephrine and vasopressin on renal kallikrein excretion in rats. Martínez Seeber A; Vila SB; Catanzaro OL Arch Int Physiol Biochim; 1985 Jun; 93(2):83-8. PubMed ID: 2412515 [TBL] [Abstract][Full Text] [Related]
20. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects. Ohman KP; Karlberg BE Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]